Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 12, 2025

阿联酋主办里程碑式峰会,开启新兴科技治理新纪元
来自 20 多个国家和地区的 2,000 多名与会者齐聚阿布扎比,参加了为期两天的高级别讨论 阿联酋阿布扎比, May 12, 2025 (GLOBE NEWSWIRE) -- 新兴技术治理峰会 (GETS 2025) 本周在阿布扎比圆满落幕。期间,与会各方强烈呼吁全球共同行动,推动治理那些重塑社会格局的技术。 本次峰会由先进技术研究委员会 (Advanced Technology Research Council) 与阿联酋检察机关 (UAE Public Prosecution) …

PageUp Unifies Brands to Strengthen Market Leadership and Enhance Customer Experience
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- PageUp, a global leader in talent acquisition software, announced the consolidation of its portfolio of brands – PageUp, eArcu, and Clinch – under the singular PageUp brand. This milestone follows PageUp’s recent …

Alation Launches Data Products Builder Agent to Power AI-Ready Data
LONDON, May 12, 2025 (GLOBE NEWSWIRE) -- Alation Inc., the data intelligence company, today announced the launch of its Data Products Builder Agent, an AI-powered tool that helps data teams turn messy, raw data into trusted, reusable data products. It …

AB Science reports its revenues for the year 2024 and provides an update on its activities
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros as of December 31, 2024, down 55% compared to December 31 …

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2024 et présente un point sur ses activités
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2024 ET LES EVENEMENTS CLEFS DE LA PERIODE Situation financière et corporate Déficit opérationnel de 6,1 millions d’euros au 31 décembre 2024 en baisse de 55% …

Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwright BioConnect au NASDAQ
PARIS and CAMBRIDGE, Mass., 12 mai 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …

Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients …

Best No Deposit Bonus Casino 2025 | MIRAX Casino Top for No Deposit Bonuses with Promo Codes
LONDON, May 12, 2025 (GLOBE NEWSWIRE) -- According to the latest industry review, MIRAX Casino has been officially ranked as the best no-deposit bonus casino available today. This recognition highlights its commitment to rewarding players with top-value …

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a joint …

Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les personnes âgées aux États-Unis
Saint Herblain (France), le 12 mai 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence de santé américaine Food and Drug Administration (FDA) et les centres américains de …

Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
Press release – No. 8 / 2025 Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …

WuBlockchain Interviews BitMart’s New CEO Nenter (Nathan) Chow: Technological Innovation, Global Expansion, and Community Empowerment
Mahe, Seychelles, May 11, 2025 (GLOBE NEWSWIRE) -- In an exclusive interview conducted by WuBlockchain, one of the cryptocurrency industry's leading media platforms, BitMart’s newly appointed CEO, Nenter (Nathan) Chow, shares the key factors behind his …

SolCex Enters a New Era: From Vision to Top-Tier Exchange Contender
Dubai, UAE, May 11, 2025 (GLOBE NEWSWIRE) -- After one year of relentless innovation and growth, SolCex is proud to announce its transition into a new phase of development. With an ambitious roadmap, deep industry partnerships, and one of the largest …